The U.S. Food and Drug Administration (FDA) has introduced a more flexible approach to regulating cell and gene therapies (CGTs), particularly in chemistry, manufacturing, and
The evolving regulatory landscape in digital health is entering a pivotal phase. The U.S. Food and Drug Administration (FDA) is signaling a more flexible approach
The global food industry is undergoing a structural transformation, driven by sustainability pressures, resource constraints, and evolving consumer preferences. Alternative proteins—once a niche segment—are now
The global energy transition is no longer a distant ambition—it is an urgent strategic priority. As volatility in fossil fuel markets continues to disrupt supply
Introduction Decarbonization has moved beyond policy ambition and sustainability pledges—it is now a defining force shaping global competitiveness, capital allocation, and innovation strategies. In 2026,
The beauty industry has always been driven by innovation—but 2026 marks a structural shift. Artificial Intelligence (AI) is no longer an experimental add-on; it is
On April 7, 2026, Biocon marked a significant milestone with the U.S. commercial launch of Bosaya™ and Aukelso™, its interchangeable denosumab biosimilars referencing blockbuster biologics
The European Union is entering a decisive phase in its sustainability journey with the implementation of the Packaging and Packaging Waste Regulation (PPWR). Effective August
The European Union is entering a decisive phase in its sustainability journey with the implementation of the Packaging and Packaging Waste Regulation (PPWR). Effective August